How Patients, Clinicians, and Communities Can Close the Healthcare Gap

Send a text

The average primary care visit lasts about 18 minutes. Complex symptoms, multiple conditions, and a maze of electronic forms don’t fit neatly into that window—and neither do the emotions that come with being sick. We sat down with advocates including a medical writer who was part of ACT UP, a sickle cell advocacy leader and a humanities scholar turned epidemiologist to unpack how patients, families, and clinicians can turn limited time into better outcomes with clearer language, smarter tools, and community trust.

We dig into the numbers behind health literacy and why discharge summaries so often miss the mark, then translate that research into steps anyone can use: keep a simple medication list, coordinate records across specialists, and lean on reliable sources like local health departments and major nonprofits. Faith Adjei-Sarpong shares how sickle cell stigma—especially around pain and opioids—creates dangerous delays in care, and how sharing real stories online and off can shift bias. Drs. Heather Duncan and Patrick Murphy explain how plain-language micro-learning helps both sides of the exam room, and how medical writers can bridge patients and providers without diluting the science.

We also surface the trust problem. The wellness industry wins attention with community and clear words, even when products are unregulated. So we talk about meeting people where trust already lives—barber shops, neighborhood centers—and why that approach worked from HIV activism to recent Mpox vaccination drives. Along the way, we address clinician burnout, the pressure of quotas, and the case for labor power in medicine to protect both providers and patients.

If you care about health equity, patient rights, and practical advocacy, this conversation gives you a roadmap: listen first, use plain language, build locally, and measure success by human impact. Subscribe, share with a friend who needs it, and tell us what you think!

Fact-check note: The pharmaceutical industry is currently valued around $1 trillion, but it is expected to exceed $3 trillion after 2030.

Thanks for listening to the Infectious Science Podcast. Be sure to visit infectiousscience.org to join the conversation, access the show notes, and don’t forget to sign up for our newsletter to receive our free materials.

We hope you enjoyed this new episode of Infectious Science, and if you did, please leave us a review on Apple Podcasts and Spotify. Please share this episode with others who may be interested in this topic!

Also, please don’t hesitate to ask questions or tell us which topics you want us to cover in future episodes. To get in touch, drop us a line in the comment section or send us a message on social media.
Instagram @Infectscipod
Facebook Infectious Science Podcast

See you next time for a new episode!